Sanofi, one of the world’s leading pharmaceutical companies, has launched a new insulin product called Toujeo Max SoloStar.

The product is designed to help people with diabetes avoid hypoglycaemia, a condition that occurs when blood sugar levels drop too low. According to Sanofi, Toujeo Max SoloStar offers stable blood sugar control with fewer episodes of hypoglycaemia compared to other insulin products on the market.

The Need for Better Insulin Products

Diabetes is a chronic condition that affects millions of people worldwide. People with diabetes have high levels of sugar (glucose) in their blood, which can cause a range of health problems if left untreated.

Insulin is a hormone that helps regulate blood sugar levels, and people with diabetes often need insulin injections to keep their blood sugar within a healthy range. However, insulin products can cause hypoglycaemia, a condition where blood sugar levels drop too low, causing symptoms such as dizziness, confusion, and in severe cases, unconsciousness or seizures.

Hypoglycaemia can be life-threatening if not treated promptly.

Sanofi developed Toujeo Max SoloStar to address this problem. The company conducted a clinical trial involving 1,049 people with diabetes who were at risk of hypoglycaemia.

The trial found that Toujeo Max SoloStar reduced the risk of hypoglycaemia by up to 31% compared to other insulin products. Additionally, Toujeo Max SoloStar provides stable blood sugar control, with fewer fluctuations in blood sugar levels throughout the day.

Features and Benefits of Toujeo Max SoloStar

Toujeo Max SoloStar is a next-generation insulin product that offers several advantages over traditional insulin products. Some of the features and benefits of Toujeo Max SoloStar include:.

Long-Acting Insulin

Toujeo Max SoloStar is a long-acting insulin product that provides consistent blood sugar control for up to 36 hours. This means that people with diabetes can take Toujeo Max SoloStar once a day, instead of multiple injections throughout the day.

Related Article Reduced episodes of hypoglycaemia with Sanofi’s new insulin

This can help streamline diabetes management and make it easier for people to stick to their treatment plan.

Low Risk of Hypoglycaemia

Toujeo Max SoloStar has been shown to reduce the risk of hypoglycaemia by up to 31% compared to other insulin products. This means that people with diabetes can use Toujeo Max SoloStar without worrying about their blood sugar dropping too low.

Hypoglycaemia is a common side effect of insulin products, and can be a major barrier to diabetes management. By reducing the risk of hypoglycaemia, Toujeo Max SoloStar can help people with diabetes stay on track with their treatment plan.

Flexibility in Dosing

Toujeo Max SoloStar offers flexibility in dosing, allowing people with diabetes to adjust their insulin dose according to their individual needs. This can help optimize blood sugar control and reduce the risk of hypoglycaemia.

Toujeo Max SoloStar comes in a pre-filled pen, which makes it easy to use and administer. The pen is also designed to be discreet and portable, allowing people with diabetes to easily manage their insulin while on the go.

Easy to Use

The Toujeo Max SoloStar pen is designed to be easy to use and administer. The pen has a large, easy-to-read dose window that displays the amount of insulin being delivered.

The pen also features an audible click that confirms the insulin has been delivered. The pen is pre-filled, meaning that people with diabetes don’t have to worry about measuring their insulin dose. The pen is also designed to be reusable, which can help reduce waste and save money over time.

Final Thoughts

Toujeo Max SoloStar is a new insulin product that offers several advantages over traditional insulin products. The product is designed to help people with diabetes avoid hypoglycaemia, a condition that can be life-threatening if not treated promptly.

Toujeo Max SoloStar provides stable blood sugar control with fewer fluctuations throughout the day, making it easier for people with diabetes to manage their condition. If you are a person with diabetes who has struggled with hypoglycaemia or inconsistent blood sugar control, Toujeo Max SoloStar may be worth exploring as an option.